Lenalidomide serves as a therapy for multiple myeloma and related blood disorders. Assisting the body in attacking malignant cells, this oral medication improves health outcomes for patients.
When a blood disorder or certain cancers need targeted therapy, this active compound often plays a role. Lenalidomide belongs to a class called immunomodulatory drugs, which means it can adjust the immune system’s activity. It is primarily used to help control abnormal cell growth in specific blood-related conditions. The ingredient appears in medicines sold under the name Lenalidomide and similar formulations.
In Singapore, the drug is regulated as a therapeutic product that must be dispensed under professional oversight. Its chemical structure is a derivative of thalidomide, but it has been modified to improve safety and effectiveness. Patients receiving lenalidomide typically do so as part of a broader treatment plan that may include other agents.
Several approved medicines list lenalidomide as the key component. In Singapore, both brand-named and generic versions are available, each containing the same active ingredient but possibly differing in packaging or price. Common forms are oral tablets that dissolve after swallowing; liquid or injectable versions are not standard for this compound. The medication label will specify the exact amount of lenalidomide per tablet.
Patients with specific blood disorders may be offered lenalidomide as part of their treatment plan. The drug is often used for multiple myeloma, a cancer that affects plasma cells in the bone marrow. It also helps people with myelodysplastic syndromes that have a particular chromosome deletion known as del(5q). In some cases, lenalidomide assists with mantle-cell lymphoma and follicular lymphoma, where it can slow disease progression. Generally, the medication is considered for adults whose disease has shown resistance to other therapies.
The drug influences the immune system and the growth of abnormal cells. It encourages certain immune cells to recognize and attack the malignant cells while also making those cells more vulnerable to other treatments. At the same time, lenalidomide can reduce the production of proteins that help cancer cells survive. This combined activity helps manage disease symptoms and may improve blood counts.
Mild side effects such as low-grade fatigue, nausea, or temporary low blood counts are frequently reported. Some patients notice mild skin rashes or mild diarrhea that usually improve with time or simple supportive care.
Rare but important warning signs include sudden shortness of breath, severe rash with blisters, unexplained bleeding, or signs of blood clots such as swelling in the leg. If any of these occur, urgent medical attention is recommended.
Lenalidomide should be avoided by individuals who are pregnant, planning to become pregnant, or breastfeeding, due to potential harm to the unborn child. People with known severe allergic reactions to lenalidomide or related compounds should also not use it. Certain heart or liver conditions may require extra caution.
Alcohol can increase the risk of dehydration and may worsen some side effects. The drug may also interact with anticoagulants, certain antibiotics, and live vaccines, potentially altering their effectiveness. Always check the medication’s package insert for a complete list of possible interactions.
Storing the tablets in a dry place away from moisture helps keep them effective. Keep the medication out of reach of children and store it at room temperature, typically below 30 °C in Singapore’s climate. Treatment courses can vary; some patients use the drug continuously, while others follow cycles that allow breaks between doses. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of lenalidomide and does not constitute medical advice. Medicines that contain this active ingredient, such as those listed under lenalidomide, may differ in formulation, strength, and usage directions. The information presented here is not a substitute for professional clinical judgment, and liability for any clinical application rests with the prescriber. Readers are encouraged to review the labeling of their specific medication and seek guidance from a qualified healthcare professional.
